Author:
Susanah Susi,Widowati Wahyu,Sari Nur Melani,Revika Revika,Kusuma Hanna,Rizal Rizal,Faried Ahmad
Abstract
Thalassemia is the most common inherited single gene blood disease worldwide and present a significant health problem in the world. Approximately, 1.5% of the global populations (An estimated 80–90 million people) are carriers of β-thalassemia. Around 5% of Indonesia population is thought to carry the thalassemia gene. The globin imbalance in β-thalassemia major causes hemolysis and ineffective erythropoiesis which results in anemia leading to increases of iron absorption. Furthermore, repeated blood transfusion and long-term increased iron absorption will lead to excessive accumulation of iron in vital organs, especially in the liver, causes liver fibrosis then leading to liver disease. Iron overload can be controlled by iron chelating drugs with the risk of side effects; therefore, a breakthrough is needed. Stem cell technology has a potential to provide novel insight in thalassemia major, through induced pluripotent stem cells (iPSCs) who has the ability to differentiate into hepatic stellate cells (HSCs)-like cells. iPSCs derived HSC-like cells (iPSC-HSCs) present the phenotypic and functional characteristics of HSCs. The utilization of iPSCs is a new option in personalized thalassemia management.
Publisher
Scientific Foundation SPIROSKI
Reference31 articles.
1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480-7. https://doi.org/10.2471/blt.06.036673 PMid:18568278
2. Wahidiyat, PA. Managing Thalassemia: Insight to Indonesian Practice. Bangkok, Thailand: Paper Presented at: The 30th Regional Congress of the ISBT; 2019. https://doi.org/10.1111/voxs.12544
3. Khandros E, Weiss MJ. Protein quality control during erythropoiesis and haemoglobin synthesis. Hematol Oncol Clin North Am. 2010;24(6):1071-88. https://doi.org/10.1016/j.hoc.2010.08.013 PMid:21075281
4. Cappellini MD, Farmakis D, Porter J, Taher A, editors. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT). 4th ed. Nicosia, Cyprus: Thalassaemia International Federation; 2021.
5. Anderson ER, Shah YM. Iron homeostasis in the liver. Compr Physiol. 2013;3(1):315-30. https://doi.org/10.1002/cphy.c120016 PMid:23720289